#1 Clinical Trials Search in Europe

Nafarelin

Nafarelin, a gonadotropin-releasing hormone (GnRH) agonist, is being studied in various clinical trials for its potential use in fertility treatments. These trials aim to evaluate the effectiveness and safety of Nafarelin in different aspects of assisted reproductive technologies, including ovarian stimulation, oocyte maturation, and luteal phase support. The research focuses on comparing Nafarelin to traditional methods and exploring new protocols to improve outcomes and patient comfort in in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) procedures.

Table of Contents

What is Nafarelin?

Nafarelin is a medication that belongs to a class of drugs called gonadotropin-releasing hormone (GnRH) agonists[1]. It is also known by its brand name Synarel[2]. GnRH agonists are substances that mimic the action of a natural hormone in your body that controls the production of sex hormones.

Uses of Nafarelin

Nafarelin is primarily used in the field of reproductive medicine, particularly in treatments related to infertility and assisted reproductive technologies. Some of its main uses include:

  • In Vitro Fertilization (IVF): Nafarelin is used in IVF protocols to help control the timing of egg maturation and ovulation[3].
  • Ovulation Induction: It can be used to trigger ovulation in women undergoing fertility treatments[1].
  • Luteal Phase Support: Some studies are investigating its use in supporting the luteal phase (the period after ovulation) during IVF cycles[4].

How Nafarelin Works

Nafarelin works by initially stimulating the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland in the brain. These hormones are crucial for the development of eggs in the ovaries. However, with continued use, Nafarelin actually suppresses the production of these hormones, which allows doctors to have precise control over the reproductive cycle during fertility treatments[1].

Administration

Nafarelin is typically administered as a nasal spray. The usual dosage is 200 micrograms (one spray) in each nostril twice daily, for a total daily dose of 400 micrograms[1][4]. However, the exact dosage and timing can vary depending on the specific treatment protocol and should always be determined by a healthcare provider.

Nafarelin in Clinical Trials

Several clinical trials are exploring new ways to use Nafarelin in fertility treatments:

  • Injection-Free IVF: One study is investigating whether using Nafarelin nasal spray to induce ovulation could make IVF treatments more comfortable for patients compared to traditional injections[3].
  • Luteal Phase Support: Another trial is comparing the use of Nafarelin for luteal phase support against traditional progesterone supplementation in IVF cycles[4].
  • Minimizing Injections: Researchers are also studying whether using nasal Nafarelin could reduce the number of injections and blood draws needed during IVF treatment[2].

Potential Side Effects

As with any medication, Nafarelin can have side effects. These may include:

  • Hot flashes
  • Headaches
  • Mood changes
  • Vaginal dryness
  • Decreased libido

It’s important to note that these side effects are generally temporary and resolve after discontinuation of the medication. Always discuss potential side effects with your healthcare provider before starting any new treatment[2].

Aspect Details
Primary Uses of Nafarelin in Trials Ovulation triggering, Luteal phase support, Ovarian stimulation
Administration Method Nasal spray
Potential Advantages Reduced injections, Lower OHSS risk, Improved patient comfort
Comparison to Traditional Methods Being compared to hCG injections and progesterone supplementation
Key Outcomes Measured Pregnancy rates, Live birth rates, Number of mature oocytes, Patient comfort
Safety Considerations Monitoring for adverse events, Assessing hormonal profiles
Types of Fertility Treatments IVF, ICSI, Frozen Embryo Transfer

FAQ

  • What is Nafarelin and how is it used in fertility treatments? Nafarelin is a gonadotropin-releasing hormone (GnRH) agonist that can be administered nasally. In fertility treatments, it's being studied for various purposes, including triggering final oocyte maturation, ovarian stimulation, and luteal phase support in IVF and ICSI procedures.
  • How does Nafarelin compare to traditional methods in IVF? Clinical trials are comparing Nafarelin to traditional methods like human chorionic gonadotropin (hCG) injections for triggering ovulation and progesterone for luteal support. Some studies suggest that Nafarelin may offer advantages in terms of patient comfort (being administered nasally) and potentially reducing the risk of ovarian hyperstimulation syndrome (OHSS).
  • Can Nafarelin help reduce injections in IVF treatments? Yes, one of the aims of using Nafarelin is to minimize injections for women undergoing IVF. Some trials are exploring the use of nasal Nafarelin as a replacement for injectable gonadotropins, which could make the treatment process more comfortable for patients.
  • What are the potential benefits of using Nafarelin in fertility treatments? Potential benefits being studied include improved patient comfort due to nasal administration, reduced risk of OHSS, possible improvements in pregnancy rates, and a more patient-friendly IVF protocol with fewer injections and blood draws.
  • Are there any known side effects or risks associated with Nafarelin use in fertility treatments? While Nafarelin is generally well-tolerated, clinical trials are ongoing to fully assess its safety profile in fertility treatments. Some studies are specifically monitoring for any adverse events related to Nafarelin use. As with any medication, it's important to discuss potential risks and side effects with a healthcare provider.

Ongoing Clinical Trials on Nafarelin

  • Study on GnRH Agonists for Ovulation and Luteal Support in IVF Patients: Comparing GnRH Agonist with hCG and Progesterone

    Recruiting

    1 1 1 1
    Investigated drugs:
    France

  • Study Comparing Intranasal Nafarelin and Subcutaneous Triptorelin for Final Egg Maturation in Women with Infertility

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Spain

Glossary

  • Gonadotropin-releasing hormone (GnRH) agonist: A medication that mimics the action of natural GnRH, stimulating the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland. In fertility treatments, it's used to control ovarian stimulation and trigger ovulation.
  • Nafarelin: A GnRH agonist administered nasally, being studied for various uses in fertility treatments including ovulation triggering and luteal phase support.
  • In Vitro Fertilization (IVF): A fertility treatment where eggs are retrieved from the ovaries and fertilized with sperm in a laboratory, with the resulting embryo(s) then transferred to the uterus.
  • Intracytoplasmic Sperm Injection (ICSI): A specialized form of IVF where a single sperm is injected directly into an egg to facilitate fertilization.
  • Ovarian Hyperstimulation Syndrome (OHSS): A potential complication of fertility treatments where the ovaries become swollen and painful due to excessive stimulation.
  • Luteal Phase Support: Hormonal support provided after ovulation or egg retrieval in fertility treatments to help prepare the uterus for embryo implantation.
  • Human Chorionic Gonadotropin (hCG): A hormone traditionally used to trigger final oocyte maturation in IVF cycles.
  • Oocyte: An immature egg cell in the ovary.
  • Embryo Transfer: The procedure of placing one or more embryos into the uterus during an IVF cycle.
  • Controlled Ovarian Hyperstimulation: The process of stimulating the ovaries to produce multiple eggs for retrieval in IVF treatments.

References

  1. https://clinicaltrials.gov/study/NCT04797338
  2. https://clinicaltrials.gov/study/NCT02865681
  3. https://clinicaltrials.gov/study/NCT04850261
  4. https://clinicaltrials.eu/trial/study-on-gnrh-agonists-for-ovulation-and-luteal-support-in-ivf-patients-comparing-gnrh-agonist-with-hcg-and-progesterone/